After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NYSE and operates within the Biotechnology industry segment. The current market capitalization of Ginkgo Bioworks Holdings Inc is $486.54M. A total of 1.13 million shares were traded on the day, compared to an average of 1.58M shares.
In the most recent transaction, Che Austin bought 2,200 shares of DNA for 8.50 per share on Nov 12 ’25. In a previous transaction on Oct 17 ’25, Coen Steven P. sold 1,312 shares at 13.65 per share. DNA shares that the insider owns now total 6,738.
Among the insiders who bought shares, Coen Steven P. acquired of 5,609 shares on Oct 21 ’25 at a per-share price of $15.00. In another insider transaction, Coen Steven P. bought 1,312 shares at $13.65 per share on Oct 21 ’25.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, DNA has a high of $17.58 and a low of $5.00.
As of this writing, DNA has an earnings estimate of -$1.8 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$1.8 per share and a lower estimate of -$1.8. The company reported an EPS of -$1.21 in the last quarter
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. DNA’s latest balance sheet shows that the firm has $1.55B in Cash & Short Term Investments as of fiscal 2021. There were $23.03M in debt and $134.76M in liabilities at the time. Its Book Value Per Share was $10.40, while its Total Shareholder’s Equity was $1.57B.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DNA is Buy with a score of 2.40.
